《中医药法》明确指出：鼓励医疗机构据临床需要配制和使用中药制剂，支持应用传统工艺配制中药制剂，支持以中医药制剂为基础研制中药新药。传统的中药制剂包括丸、散、膏、丹等多种形式，是中医的特色优势所在，更是传统中医药文化传播的载体。医院中药制剂具有临床反复实践、疗效确切的特点，在临床工作中起着不可替代的作用。为了推动医院中药制剂的发展，立足于我国医院中药制剂政策沿革与现状，初步剖析了医院中药制剂发展存在的共性问题，结合医院中药制剂不合理用药现状，分析其存在问题及干预措施，着重探讨了新形式下医院中药制剂的发展模式，并统计分析近10年国家自然科学基金对中药制剂的资助情况及经费投入，深度数据挖掘为寻求中药院内制剂研究方向提供参考。

Traditional Chinese Medical law clearly pointed out:Medical institutions should be encouraged to prepare and use traditional Chinese medicine (TCM) preparations according to the clinical needs. The traditional techniques of TCM preparations and the new TCM based on TCM preparations were be supported. TCM preparations(including pills, powders, pastes, recipes) were deemed to characteristic superiority and the vector of TCM cultural transmission. Hospital preparations of TCM has played an irreplaceable role in clinical work with the characteristics of repeated clinical practice and definite therapeutic effect. In order to promote the development of TCM hospital preparation, this paper focused on the development pattern of TCM hospital preparation under the new policy based on TCM hospital preparations policy history, current situation, common problems, rational drugs use, and mined data of grants and funding of National Natural Science Foundation in the past 10 years for seeking research direction of TCM hospital preparations.

全国中药特色技术传承人才培训项目实施方案（国中医药办人教发（2014）39号）；全国老中医药专家学术经验传承工作室（国中医药人教发（2017）29号）